AGILENT BIOPHARMA CDX SERVICES LABORATORY
Live / Applied — First extension granted (statement of use) (as of 09 Jun 2025)
What this means for you
Not registered yet, but its 21 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98461563
- Mark type
- Stylized text
- Filed
- 21 Mar 2024
- Published for opposition
- 29 Oct 2024
- Attorney of record
- Andrew Roppel
Goods and services
- Class 042 — Scientific and technological services: Scientific laboratory services; Scientific laboratory services in the field of pharmaceuticals, biopharmaceuticals, companion diagnostics, and biotherapeutic products; Laboratory research services relating to pharmaceuticals, biopharmaceuticals, companion diagnostics, and biotherapeutic products; Pharmaceutical and biopharmaceutical drug development services; Scientific and technological consulting services in the pharmaceutical industry in the field of companion diagnostics, and research and design relating thereto
Owner
- Agilent Technologies, Inc., Santa Clara, CA, US
- Agilent Technologies, Inc., Santa Clara, CA, US
Prior registrations
Prosecution history
- 26 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jun 2025 — SOU EXTENSION 1 GRANTED
- 09 Jun 2025 — SOU EXTENSION 1 FILED
- 09 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION
- 09 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED